AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 84 of 105

85 1 Monitor adherence and response to therapy 1 Intensify LDL–C- lowering therapy * Conversion of triglyceride from mg/dL to mmol/L: 150 mg/dL=1.7 mmol/L, 175 mg/dL=2 mmol/L, 500 mg/dL to 5.7 mmol/L, 1000 mg/dL=11.3 mmol/L. ASCVD indicates atherosclerotic cardiovascular disease; ETOH, ethyl alcohol; HDL-C, high- density lipoprotein-cholesterol; and LDL-C, low-density lipoprotein-cholesterol. Adapted from Virani et al.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026